J&J to buy Intra-Cellular Therapies for $14.6 billion-February 2024-www.financetom.com

J&J to buy Intra-Cellular Therapies for $14.6 billion

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

J&J to buy Intra-Cellular Therapies for $14.6 billion

Jan 13, 2025 4:05 AM

Jan 13 (Reuters) - Johnson & Johnson ( JNJ ) said on

Monday it would buy drugmaker Intra-Cellular Therapies ( ITCI )

for $14.6 billion, boosting its presence in the market for

neurological disorder treatments.

Previous page： Market Chatter: BlackRock's India JV to Launch Nearly Dozen New Funds Next page：

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Market Chatter: BlackRock's India JV to Launch Nearly Dozen New Funds

Jul 8, 2025

07:09 AM EDT, 07/08/2025 (MT Newswires) -- BlackRock's ( BLK ) joint venture in India, Jio BlackRock Asset Management, plans to launch nearly a dozen new equity and debt mutual funds in India by the end of the year, Reuters reported Tuesday. The fund will target small-ticket investors and avoid traditional distributors to keep costs low, the report said, citing...

Jul 8, 2025

...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Jul 8, 2025

...